ExxonMobil Investment Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$2.08M Sell
20,765
-907
-4% -$92.9K 0.06% 348
2017
Q4
$2.13M Sell
21,672
-3,238
-13% -$307K 0.06% 351
2017
Q3
$2.33M Sell
24,910
-1,360
-5% -$144K 0.06% 347
2017
Q2
$2.92M Sell
26,270
-4,263
-14% -$451K 0.07% 297
2017
Q1
$3M Sell
30,533
-1,558
-5% -$149K 0.07% 326
2016
Q4
$2.95M Sell
32,091
-3,405
-10% -$293K 0.07% 330
2016
Q3
$3M Sell
35,496
-1,120
-3% -$94.1K 0.06% 341
2016
Q2
$2.98M Buy
36,616
+1,858
+5% +$141K 0.06% 342
2016
Q1
$2.48M Buy
34,758
+2,627
+8% +$176K 0.06% 369
2015
Q4
$2.29M Sell
32,131
-823
-2% -$55.3K 0.06% 360
2015
Q3
$2.03M Buy
32,954
+1,067
+3% +$74.6K 0.05% 390
2015
Q2
$2.31M Sell
31,887
-2,817
-8% -$208K 0.06% 366
2015
Q1
$2.67M Buy
34,704
+629
+2% +$45K 0.06% 358
2014
Q4
$2.29M Sell
34,075
-1,313
-4% -$82.9K 0.05% 379
2014
Q3
$2.15M Sell
35,388
-1,372
-4% -$84.5K 0.05% 395
2014
Q2
$2.16M Sell
36,760
-1,033
-3% -$60.5K 0.05% 408
2014
Q1
$2.19M Sell
37,793
-63
-0.2% -$3.38K 0.05% 398
2013
Q4
$2.03M Sell
37,856
-2,524
-6% -$150K 0.05% 408
2013
Q3
$2.5M Sell
40,380
-3,532
-8% -$211K 0.06% 350
2013
Q2
$2.66M Buy
+43,912
New +$2.62M 0.07% 335

Other funds holding DGX

ExxonMobil Investment Management's DGX Position: Q1 2018 in Review

ExxonMobil Investment Management reduced its Quest Diagnostics (DGX) stake by 4.2% in Q1 2018, selling an estimated $92.9K and leaving 20,765 shares worth $2.08M. The position accounts for 0.06% of the portfolio, ranked #348.

ExxonMobil Investment Management first reported a position in DGX in Q2 2013 and has held it in 20 quarters since. The position peaked at $3M in Q3 2016. 653 funds tracked by Wall St. Rank hold DGX as of Q1 2018.

  • ExxonMobil Investment Management held 20,765 shares of Quest Diagnostics worth $2.08M as of Q1 2018.
  • ExxonMobil Investment Management sold 907 Quest Diagnostics shares in Q1 2018, an estimated $92.9K.
  • Quest Diagnostics made up 0.06% of ExxonMobil Investment Management's portfolio in Q1 2018, its #348 holding.
  • ExxonMobil Investment Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 20 quarters since.
  • ExxonMobil Investment Management's Quest Diagnostics position peaked at $3M in Q3 2016.
  • 653 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2018.

Based on ExxonMobil Investment Management's 13F filing for Q1 2018, filed 12 Apr 2018.